![Keigo Tsujimoto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keigo Tsujimoto
Corporate Officer/Principal chez
LINICAL CO., LTD.
Fortune : 1 M $ au 30/06/2026
Profil
Keigo Tsujimoto is Director at Linical USA, Inc. since 2015, Director at Linical Accelovance America, Inc. since 2018, and Global Chief Project Officer at Linical Co., Ltd. since 2024.
Formerly, Mr. Tsujimoto was President & Representative Director at Linical Europe Holding GmbH.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LINICAL CO., LTD. 4,14 % | 30/09/2025 | 1 024 000 ( 4,14 % ) | 1 M $ | 30/06/2026 |
Postes actifs de Keigo Tsujimoto
| Sociétés | Poste | Début |
|---|---|---|
| LINICAL CO., LTD. | Corporate Officer/Principal | 01/02/2008 |
Linical USA, Inc.
 Linical USA, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services | Directeur/Membre du Conseil | 01/07/2008 |
Linical Accelovance America, Inc.
 Linical Accelovance America, Inc. Medical/Nursing ServicesHealth Services The company is based in Stuart. Linical Accelovance America, Inc. is a mid-sized contract research organization specializing in comprehensive drug development and clinical trial management services across all phases, from early phase studies to large-scale multinational late-phase trials. The American company provides expertise in drug development strategy, regulatory consulting, clinical trial feasibility and start-up, project management, medical affairs, pharmacovigilance, clinical monitoring, patient recruitment, biometrics, quality assurance, and medical writing. Linical focuses on therapeutic areas such as oncology, neurology and psychiatry, immunology and vaccines, endocrinology and metabolic diseases, biosimilars, rare diseases, and pediatrics. The company leverages local expertise in language, culture, patient populations, and regulatory environments to optimize trial design and ensure compliance with regulations across major markets. Linical integrates advanced technology, standardized processes, real-time project insights, and predictive analytics to deliver data efficiently. The company also supports investigator networks and offers a knowledge hub with research articles and industry resources, while investing in AI and digital tools to enhance operational efficiency and service quality. Linical Accelovance America was founded in 2004. | Directeur/Membre du Conseil | 01/04/2018 |
Anciens postes connus de Keigo Tsujimoto
| Sociétés | Poste | Fin |
|---|---|---|
Linical Europe Holding GmbH
 Linical Europe Holding GmbH Medical/Nursing ServicesHealth Services Operates as a holding company with interests in pharmaceutical research and development | President | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Linical Co., Ltd.
 Linical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services to pharmaceutical companies | Commercial Services |
Linical USA, Inc.
Linical USA, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Linical Europe Holding GmbH
Linical Europe Holding GmbH Medical/Nursing ServicesHealth Services Operates as a holding company with interests in pharmaceutical research and development | Health Services |
Linical Accelovance America, Inc.
Linical Accelovance America, Inc. Medical/Nursing ServicesHealth Services The company is based in Stuart. Linical Accelovance America, Inc. is a mid-sized contract research organization specializing in comprehensive drug development and clinical trial management services across all phases, from early phase studies to large-scale multinational late-phase trials. The American company provides expertise in drug development strategy, regulatory consulting, clinical trial feasibility and start-up, project management, medical affairs, pharmacovigilance, clinical monitoring, patient recruitment, biometrics, quality assurance, and medical writing. Linical focuses on therapeutic areas such as oncology, neurology and psychiatry, immunology and vaccines, endocrinology and metabolic diseases, biosimilars, rare diseases, and pediatrics. The company leverages local expertise in language, culture, patient populations, and regulatory environments to optimize trial design and ensure compliance with regulations across major markets. Linical integrates advanced technology, standardized processes, real-time project insights, and predictive analytics to deliver data efficiently. The company also supports investigator networks and offers a knowledge hub with research articles and industry resources, while investing in AI and digital tools to enhance operational efficiency and service quality. Linical Accelovance America was founded in 2004. | Health Services |
